173 related articles for article (PubMed ID: 29511373)
1. SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer.
Chang IW; Liu KW; Ragunanan M; He HL; Shiue YL; Yu SC
Int J Med Sci; 2018; 15(4):376-384. PubMed ID: 29511373
[No Abstract] [Full Text] [Related]
2. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
[TBL] [Abstract][Full Text] [Related]
3. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
[TBL] [Abstract][Full Text] [Related]
4. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
Chen TJ; He HL; Shiue YL; Yang CC; Lin LC; Tian YF; Chen SH
Int J Med Sci; 2018; 15(11):1171-1178. PubMed ID: 30123054
[No Abstract] [Full Text] [Related]
5. High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Tian YF; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Solórzano J; Li CF; Chang IW
J Cancer; 2017; 8(7):1197-1204. PubMed ID: 28607594
[No Abstract] [Full Text] [Related]
6. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF
Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104
[TBL] [Abstract][Full Text] [Related]
9. High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.
Lin SC; Chang IW; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Tian YF
J Cancer; 2017; 8(14):2756-2764. PubMed ID: 28928864
[No Abstract] [Full Text] [Related]
10. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.
Lin CY; Sheu MJ; Li CF; Lee SW; Lin LC; Wang YF; Chen SH
Tumour Biol; 2014 Jul; 35(7):6823-30. PubMed ID: 24729124
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ
Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927
[TBL] [Abstract][Full Text] [Related]
12. REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT.
Li WS; Chen TJ; Lee SW; Yang CC; Tian YF; Kuo YH; Tsai HH; Wu LC; Yeh CF; Shiue YL; Chou CL; Lai HY
Histol Histopathol; 2024 Jan; 39(1):91-104. PubMed ID: 37042618
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
[TBL] [Abstract][Full Text] [Related]
14. VNN1 overexpression is associated with poor response to preoperative chemoradiotherapy and adverse prognosis in patients with rectal cancers.
Chai CY; Zhang Y; Song J; Lin SC; Sun S; Chang IW
Am J Transl Res; 2016; 8(10):4455-4463. PubMed ID: 27830030
[TBL] [Abstract][Full Text] [Related]
15. CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT.
Chou CL; Chen TJ; Tian YF; Chan TC; Yeh CF; Li WS; Tsai HH; Li CF; Lai HY
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357018
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH
Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619
[TBL] [Abstract][Full Text] [Related]
17. High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.
Chen TJ; Chou CL; Tian YF; Yeh CF; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
Int J Clin Oncol; 2021 Sep; 26(9):1689-1697. PubMed ID: 34043102
[TBL] [Abstract][Full Text] [Related]
18. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.
Shim BY; Sun S; Won HS; Lee MA; Hong SU; Jung JH; Cho HM; Ko YH
BMC Cancer; 2016 Mar; 16():207. PubMed ID: 26965179
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
[No Abstract] [Full Text] [Related]
20. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT.
Chen HP; Chen CI; Liu KW; Chen TJ; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Li CF; Chou CL; Lai HY
Pathol Res Pract; 2022 Nov; 239():154158. PubMed ID: 36244249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
